162 related articles for article (PubMed ID: 8788075)
1. Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms.
Armstrong RA; Winsper SJ; Blair JA
Dementia; 1996; 7(1):1-9. PubMed ID: 8788075
[TBL] [Abstract][Full Text] [Related]
2. Aluminium, amyloid, and Alzheimer's disease.
Mera SL
Med Lab Sci; 1991 Oct; 48(4):283-95. PubMed ID: 1811120
[TBL] [Abstract][Full Text] [Related]
3. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.
Harrington CR; Wischik CM; McArthur FK; Taylor GA; Edwardson JA; Candy JM
Lancet; 1994 Apr; 343(8904):993-7. PubMed ID: 7909090
[TBL] [Abstract][Full Text] [Related]
5. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW; Lee VM; Trojanowski JQ
Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
[TBL] [Abstract][Full Text] [Related]
8. Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease.
Smith MA; Siedlak SL; Richey PL; Mulvihill P; Ghiso J; Frangione B; Tagliavini F; Giaccone G; Bugiani O; Praprotnik D
Nat Med; 1995 Apr; 1(4):365-9. PubMed ID: 7585068
[TBL] [Abstract][Full Text] [Related]
9. Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system.
Edwardson JA; Candy JM; Ince PG; McArthur FK; Morris CM; Oakley AE; Taylor GA; Bjertness E
Ciba Found Symp; 1992; 169():165-79; discussion 179-85. PubMed ID: 1490421
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
Spillantini MG; Crowther RA; Goedert M
Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124
[TBL] [Abstract][Full Text] [Related]
11. Amyloid, aluminium and the aetiology of Alzheimer's disease.
Storey E; Masters CL
Med J Aust; 1995 Sep; 163(5):256-9. PubMed ID: 7565212
[TBL] [Abstract][Full Text] [Related]
12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
13. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.
Lantos PL; Luthert PJ; Hanger D; Anderton BH; Mullan M; Rossor M
Neurosci Lett; 1992 Mar; 137(2):221-4. PubMed ID: 1584463
[TBL] [Abstract][Full Text] [Related]
14. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
15. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
16. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
Shin RW
Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
[TBL] [Abstract][Full Text] [Related]
17. Truncated tau protein as a new marker for Alzheimer's disease.
Novák M
Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.
Wischik CM; Harrington CR; Mukaetova-Ladinska EB; Novak M; Edwards PC; McArthur FK
Ciba Found Symp; 1992; 169():268-93; discussion 293-302. PubMed ID: 1490426
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.
Yumoto S; Kakimi S; Ohsaki A; Ishikawa A
J Inorg Biochem; 2009 Nov; 103(11):1579-84. PubMed ID: 19744735
[TBL] [Abstract][Full Text] [Related]
20. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
